CAICaris Life Sciences, Inc.

$26.82

Who owns CAI

200 institutions reported holding CAI for 2026Q1, together 56% of the company, more than the 185 a quarter earlier.

200

Institutions reporting a position · as of 2026Q1 · up from 185 the quarter before

Shares held by institutions
156.9M

Shares held by institutions · 56% of the company · long US equity positions only, as reported on Form 13F

Reported value
$2.80B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
29%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
4
New positions
52
Positions exited
42
Added to
87
Reduced
37
Top 10 holdersof the company
39%
Institutional ownership by quarter, 2025Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1200156.9M$2.80B
2025Q4185145.3M$3.92B
2025Q3138113.4M$3.41B
2025Q2116109.3M$2.92B
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC30.8M11%$550M
J. H. Whitney Equity Partners VI, LLC18.3M6.5%$326M
Sixth Street Partners Management Company, L.P.14.4M5.1%$257M
COATUE MANAGEMENT LLC9.8M3.5%$176M
BRAIDWELL LP8.0M2.8%$143M
PointState Capital LP7.4M2.6%$132M
VANGUARD GROUP INC7.2M2.6%$129M
T. Rowe Price Investment Management, Inc.5.6M2.0%$100M
BlackRock Inc.4.9M1.7%$87M
PRICE T ROWE ASSOCIATES INC /MD/4.4M1.5%$78M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…